papaverine has been researched along with nicorandil in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ogawa, N; Ono, H | 1 |
Endoh, M; Taira, N; Yanagisawa, T | 1 |
Hongo, M; Nakatsuka, T; Sekiguchi, M; Takenaka, H; Uchikawa, S; Watanabe, N | 1 |
Dohi, K; Fujimoto, S; Hashimoto, T; Inoue, F; Kawamoto, A; Uemura, S | 1 |
Gen, H; Himura, Y; Hirozane, T; Iga, K; Inoko, M; Izumi, C; Kitaguchi, S; Kondo, H; Konishi, T; Tamura, T | 1 |
Duan, T; Kong, R; Song, R; Xiang, D; Xu, D; Zhang, J | 1 |
Arai, T; Masaki, R; Matsumoto, H; Mikuri, M; Ogura, K; Oishi, Y; Okada, N; Sakai, R; Shinke, T; Tanaka, H | 1 |
Anai, R; Araki, M; Inoue, K; Kataoka, M; Miura, T; Naka, Y; Okabe, H; Setoyama, K; Sonoda, S | 1 |
1 trial(s) available for papaverine and nicorandil
Article | Year |
---|---|
Coronary microvascular response to intracoronary administration of nicorandil.
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Microcirculation; Middle Aged; Niacinamide; Nicorandil; Papaverine; Vascular Resistance; Vasodilator Agents | 1995 |
8 other study(ies) available for papaverine and nicorandil
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Different effects of various vasodilators on autoregulation of renal blood flow in anesthetized dogs.
Topics: Animals; Blood Pressure; Diltiazem; Dogs; Female; Homeostasis; Male; Niacinamide; Nicorandil; Nitroglycerin; Nitroprusside; Papaverine; Renal Circulation; Sodium Nitrite; Vasodilator Agents | 1986 |
Effects of 2-nicotinamidethyl nitrate (SG-75), a new antianginal drug, on the cyclic AMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Niacinamide; Nicorandil; Nitrates; Papaverine; Vasodilator Agents | 1980 |
Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.
Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vessels; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Nicorandil; Papaverine; Vasodilator Agents | 1998 |
[Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Papaverine; Ultrasonics; Vasodilator Agents | 2000 |
Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
Topics: Adenosine Triphosphate; Alprostadil; Animals; Coronary Circulation; Microcirculation; Nicorandil; Papaverine; Swine; Vasodilator Agents | 2019 |
Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: Comparison with intracoronary papaverine.
Topics: Coronary Angiography; Coronary Circulation; Coronary Stenosis; Feasibility Studies; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Nicorandil; Papaverine; Vasodilator Agents | 2020 |
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Incidence; Long QT Syndrome; Male; Middle Aged; Nicorandil; Papaverine; Retrospective Studies; Safety; Tachycardia, Ventricular; Treatment Outcome; Vasodilator Agents | 2021 |